3.63 USD
↗ 0.12 (3.43%)AT CLOSE (AS OF 07:31 PM EDT)
X4 Pharmaceuticals, Inc. Common Stock
XFORNASDAQ • USD
Market: CLOSED
Shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) are trading at $3.63. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, XFOR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 14, 2026.
Open?$3.51
High?$3.71
Low?$3.47
Prev. Close?$3.50
Volume?1.0M
Avg. Volume?782.8K
VWAP?$3.64
Rel. Volume?1.30x
Bid / Ask
Bid?$3.08 × 100
Ask?$4.12 × 100
Spread?$1.04
Midpoint?$3.60
Valuation & Ratios
Market Cap?347.0M
Shares Out?99.1M
Float?86.0M
Float %?86.8%
P/E Ratio?N/A
P/B Ratio?2.23
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Employees
45
Market Cap
347.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-11-16
Address
61 NORTH BEACON STREET
BOSTON, MA 02134
Phone: 857-529-8300
BOSTON, MA 02134
Phone: 857-529-8300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?97
Short Sent.?48
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.50Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?8.36%Elevated
Short Interest?7.2M
Days to Cover?12.8
Free Float86.0M
Avg Daily Volume560.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?11.30Strong
Quick Ratio?11.02Strong
Cash Ratio?10.07Strong
Debt/Equity?0.49Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.23CHEAP▾
Peers100
S&P69
P/S?21.90HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
S&P97
EV/Sales?14.43HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-58.0%WEAK▾
S&P3
ROA?-35.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$228.7M
Fundamentals ratios updated end of day